drugset / Trial / NCT00704782

Study of Combination Therapy With Dimebon and Donepezil (Aricept) in Patients With Alzheimer's Disease

NCT00704782 ↗

Phase 2 Terminated 50 enrolled Medivation, Inc.
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to assess the safety and efficacy of Dimebon in combination with donepezil (Aricept) in the treatment of Alzheimer's disease.

Timeline

Start
2008-04
Primary completion
2010-08
Completion
2010-08

Outcome

Outcome not reported

Stopped: “The study was halted after a Phase 3 study of dimebon failed to show efficacy.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Latrepirdine Small molecule 20 mg Oral

Indications